EE201100041A - Mittetstotoksiline alfaviiruskonstrukt, rakuliin ja kompositsioon ning meetod viirusvastaste hendite m?ju tuvastamiseks - Google Patents

Mittetstotoksiline alfaviiruskonstrukt, rakuliin ja kompositsioon ning meetod viirusvastaste hendite m?ju tuvastamiseks

Info

Publication number
EE201100041A
EE201100041A EEP201100041A EEP201100041A EE201100041A EE 201100041 A EE201100041 A EE 201100041A EE P201100041 A EEP201100041 A EE P201100041A EE P201100041 A EEP201100041 A EE P201100041A EE 201100041 A EE201100041 A EE 201100041A
Authority
EE
Estonia
Prior art keywords
toxic
composition
cell line
antiviral agents
detecting effect
Prior art date
Application number
EEP201100041A
Other languages
English (en)
Inventor
Lulla Aleksei
Merits Andres
Utt Age
Varjak Margus
Original Assignee
Tartu Ülikool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tartu Ülikool filed Critical Tartu Ülikool
Priority to EEP201100041A priority Critical patent/EE201100041A/et
Priority to PCT/EE2012/000003 priority patent/WO2012159638A1/en
Publication of EE201100041A publication Critical patent/EE201100041A/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/36011Togaviridae
    • C12N2770/36111Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36121Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/36011Togaviridae
    • C12N2770/36111Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/36011Togaviridae
    • C12N2770/36111Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36141Use of virus, viral particle or viral elements as a vector

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EEP201100041A 2011-05-23 2011-05-23 Mittetstotoksiline alfaviiruskonstrukt, rakuliin ja kompositsioon ning meetod viirusvastaste hendite m?ju tuvastamiseks EE201100041A (et)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EEP201100041A EE201100041A (et) 2011-05-23 2011-05-23 Mittetstotoksiline alfaviiruskonstrukt, rakuliin ja kompositsioon ning meetod viirusvastaste hendite m?ju tuvastamiseks
PCT/EE2012/000003 WO2012159638A1 (en) 2011-05-23 2012-05-23 Non-cytotoxic alpha viral construct, cell line and composition and a method for the assessment of the effect of antiviral agents.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EEP201100041A EE201100041A (et) 2011-05-23 2011-05-23 Mittetstotoksiline alfaviiruskonstrukt, rakuliin ja kompositsioon ning meetod viirusvastaste hendite m?ju tuvastamiseks

Publications (1)

Publication Number Publication Date
EE201100041A true EE201100041A (et) 2013-02-15

Family

ID=46317075

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP201100041A EE201100041A (et) 2011-05-23 2011-05-23 Mittetstotoksiline alfaviiruskonstrukt, rakuliin ja kompositsioon ning meetod viirusvastaste hendite m?ju tuvastamiseks

Country Status (2)

Country Link
EE (1) EE201100041A (et)
WO (1) WO2012159638A1 (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104404167A (zh) * 2014-10-30 2015-03-11 薛芳 基孔肯雅病毒核酸分子特征标准样品及其制备方法
WO2018147802A1 (en) * 2017-02-07 2018-08-16 Agency For Science, Technology And Research Alphavirus nsp mutants as vaccines

Also Published As

Publication number Publication date
WO2012159638A1 (en) 2012-11-29

Similar Documents

Publication Publication Date Title
PL2841390T3 (pl) Stabilne wymiarowo kompozycje geopolimerów i metoda
ZA201403503B (en) Thieno- and furo - pyrimidines and pyridines, useful as potassium channel inhibitors
HRP20181515T1 (hr) Mezenhimne stromalne stanice i upotreba povezana s njima
BR112013033811A2 (pt) composição, método de preparação da composição, e, composto
PL2884999T3 (pl) Sposób i kompozycje do immunoterapii komórkowej
BR112013010725A2 (pt) método, e, composição
PL3863288T3 (pl) Sposoby intra-predykcji i środek nośnikowy
BR112014010450A2 (pt) composição e método
PL2729404T3 (pl) Sposób równoległego wytwarzania wodoru, tlenku węgla i zawierających węgiel produktów
ME03766B (me) Određeni amino-pirimidini, njihove kompozicije, i metode njihove upotrebe
LT2755473T (lt) Paraziticidinės kompozicijos, apimančios izoksazolino veiklųjį agentą, būdai ir jų panaudojimai
PL2533761T3 (pl) Sposoby i kompozycje do wytwarzania aerozoli
EP2757885A4 (en) Specific chemical substances, compositions and methods
EP2747767A4 (en) Specific chemical substances, compositions and methods
PL3564361T3 (pl) Organoid wątroby, jego zastosowanie i sposoby hodowlane jego otrzymywania
EP2755657A4 (en) Specific chemical substances, compositions and methods
BR112013030187A2 (pt) pista para torre
PL2569260T3 (pl) Kompozycja powlekająca, sposób i wyrób
EP2688503A4 (en) ablation
BR112014008471A2 (pt) método de cimentação e composição de escória
SG10201602147YA (en) Methods And Compositions For Predicting Response To Eribulin
EP2678305A4 (en) CHALCONE DERIVATIVES AS NRF2 ACTIVATORS
CO6900148A2 (es) Inhibidores de la enzima activadora de nedd8
BR112013022306A2 (pt) método, e, composição
BR112013022254A2 (pt) método e disposição para gerar oxigênio